Sure. If the only effect were on under-30s, this wouldn’t be a great vaccine. What 5,000 people is good for, however, is confidently measuring decline in a cohort. Zero deaths, even against a baseline of tens, strongly implies this should cross into the tend or hundreds of thousands over the next decades in populations that keep vaccination rates up.
Oddly enough I can't find exact death rates from cervical cancer paired amongst those who had HIV/AIDS but this [2] hints at it, with 90% of all cervical cancer deaths coming in low/middle income countries, and with the "highest burden" (plurality I guess?) coming from sub-Saharan Africa where rates of HIV are the highest. [2]
[1] - https://pmc.ncbi.nlm.nih.gov/articles/PMC7815633/
[2] - hhttps://www.unaids.org/en/resources/presscentre/featurestori...
It's not zero deaths though, it's "almost zero".
4,462 out of the whole population (of women etc.).
Would you subjectively describe that number as "almost zero"?